Does radiation prevent 5-Fluouracil induced colitis?

被引：0
|
作者：
Rischke, C. [1 ]
Momm, F. [1 ]
Henke, M. [1 ]
Frommhold, H. [1 ]
机构：
[1] Univ Freiburg Klinikum, Inst Klin Strahlenkunde, Freiburg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1038
引用
收藏
页码：S423 / S424
页数：2
相关论文
共 50 条
  • [21] A prospective pilot study of pharmacogenetic-based dosing of 5-fluouracil (5-FU) and irinotecan (IRI) in patients (pts) with gastrointestinal (GI) malignancies.
    Chi, Jeffrey
    Hakim, Nausheen
    Rehman, Hasan
    Moriarty, Linda
    Maloney, Antonia
    Smith, Melissa H.
    Jose, Jyothi
    Saif, Wasif M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Potential application of GSTT1-null genotype in predicting toxicity associated to 5-fluouracil irinotecan and leucovorin regimen in advanced stage colorectal cancer patients
    Romero, R. Zarate
    Morales, R.
    Garcia, F.
    Huarriz, M.
    Bandres, E.
    De la Haba, J.
    Gomez, A.
    Aranda, E.
    Garcia-Foncillas, J.
    ONCOLOGY REPORTS, 2006, 16 (03) : 497 - 503
  • [23] TREATMENT OF METASTATIC PROSTATIC CANCER WITH 5-FLUOURACIL (5-FU) VERSUS 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (CCNU)
    TEJADA, F
    BRODER, LE
    COHEN, MH
    SIMON, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 269 - 269
  • [24] Gamma radiation does not prevent transfusion-induced HLA alloimmunization
    Ohto, H
    TRANSFUSION, 1997, 37 (08) : 878 - 879
  • [25] Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase
    Smorenburg, CH
    Peters, GJ
    van Groeningen, CJ
    Noordhuis, P
    Smid, K
    van Riel, AMGH
    Dercksen, W
    Pinedo, HM
    Giaccone, G
    ANNALS OF ONCOLOGY, 2006, 17 (01) : 35 - 42
  • [26] Does Ulcerative Colitis prevent the development of colonic diverticulosis?
    Mantzaris, G.
    Archavlis, E.
    Christidou, A.
    Papamichael, K.
    Kyriakos, N.
    Karatzas, P.
    Tzannetakou, X.
    Anastasiadis, S.
    Internos, I.
    Varytimiadis, L.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S403 - S403
  • [27] First line tailored chemotherapy in advanced colorectal cancer (ACRC) with 5-fluouracil/leucovorin (5FU/LV) oroxaliplatin/irinotecan chosen by the expression of thymidylate synthase (TS) and dihydropyrimidine (DPD).
    Smorenburg, CH
    Peters, GJ
    Van Groeningen, CJ
    Noordhuis, P
    Van Riel, JM
    Pinedo, HM
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 275S - 275S
  • [28] Binding of Hydrogen Sulfide by Bismuth Does Not Prevent Dextran Sulfate-Induced Colitis in Rats
    Julie K. Furne
    Fabrizis L. Suarez
    Stephen L. Ewing
    John Springfield
    Michael D. Levitt
    Digestive Diseases and Sciences, 2000, 45 : 1439 - 1443
  • [29] Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats
    Furne, JK
    Suarez, FL
    Ewing, SL
    Springfield, J
    Levitt, MD
    DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) : 1439 - 1443
  • [30] Does 5ASA Therapy Prevent the Development of Premalignant Polyps in Chronic Idiopathic Ulcerative Colitis?
    Mathur, Siddharth
    Atluri, Sreedevi
    Olaywi, Manhal
    Tejada, Juan
    Changela, Kinesh
    Jibara, Ghalib
    Anand, Sury
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S681 - S681
12345